IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study

Clinical trial NCT07596888 · RECRUITING

Trial details

NCT number: NCT07596888
Sponsor: University of North Carolina, Chapel Hill
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HIV-1-infection

Start date: 2026-06-18
Primary completion: 2027-05-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.